Kestrel Group Reports Second Quarter 2026 Financial Results
Go back to Kestrel Group Reports Second Quarter 2026 Financial Results| KING PHARMACEUTICALS (NASDAQ: KG) | Delayed: 7.60 -0.29 (3.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.89 | 52 Week High | $14.26 | |||
| Open | $7.74 | 52 Week Low | $7.18 | |||
| Day High | $8.01 | P/E | 22.35 | |||
| Day Low | $7.51 | EPS | $0.34 | |||
| Volume | 12,932 | |||||

